Klotho and lean mass as novel cardiovascular risk factors in hemodialysis patients.

"CONFLICT OF INTEREST STATEMENT A.R.M. has received consulting fees from Viforpharma and Amgen and payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Viforpharma. A.R.M. also received support for attending meetings and/or travel from Viphorfarma and MSD and had a leadership or fiduciary role in the Portuguese Nephrology Society. A.L.W. has received consulting fees and payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Alexion, Astellas, AstraZeneca and Takeda. A.L.W. participated on a Data Safety Monitoring Board or Advisory Board of Alexion, Astellas, AstraZeneca and Takeda. All the other authors declare no conflicts of interest."

"FUNDING This study was supported by Davita Portugal."